Proteome Sciences PLC (PRM)

Industry Diagnostics & Research

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

2.04p

Buy

2.58p

arrow-down-0.05p (-2.12%)

Prices updated at 12 Dec 2025, 15:52 GMT

Prices minimum 15 mins delay

Prices in GBX

Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for prognostic and therapeutic applications.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. Christopher Donovan James Pearce

CEO

-

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

29

Head office

Downside Bridge Road

Cobham

United Kingdom

KT11 3EP

+44 2070432116

helpdesk@proteomics.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Roger Steven McDowell Non-Executive Director	-
Mr. Martin Henry Diggle Non-Executive Director	-
Dr. Ian Pike Executive Director, Chief Scientific Officer	-
Mr. Richard Paul Dennis Executive Director, Chief Commercial Officer	-
Mr. Christopher Donovan James Pearce Executive Director, Chairman	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
No data

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.